Skip to content
Hope Pharmacy
Searle

Optra Nebuliser Solution 500mcg 2ml 10 Vials

A inhaler containing Ipratropium Bromide, indicated for Chronic Obstructive Pulmonary Disease.

Rs. 955

60ml Drops

In StockSet your city for an exact delivery date

In stock at selected branches

Quantity
Optra Nebuliser Solution 500mcg 2ml 10 Vials quantity: 1
  • 100% authentic
  • Free over Rs. 1,500
  • Pharmacist verified
  • 7-day returns

Total for 1 pack: Rs. 955

What it is used for: Chronic Obstructive Pulmonary Disease.

Indications as listed by the manufacturer: Ipratropium bromide is indicated as: - Bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. - Adjunct to beta2-agonists in the management of acute severe asthma.

How it works: Ipratropium bromide is an anticholinergic (parasympatholytic) agent it appears to inhibits the vagally mediated reflexes by antagonising the action of acetylcholine, the transmitter agent released from the vagus nerve. Anticholinergics prevent the increase in intracellular concentration of Ca++ which is caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle. The bronchodilation following inhalation of ipratropium bromide is induced by local drug concentrations sufficient for anticholinergic efficacy at the bronchial smooth muscle and not by systemic concentrations.

Active ingredient: Ipratropium Bromide.

Reported side effects: Common: Headache, dizziness, cough, throat irritation, nausea, dryness of mouth and gastrointestinal motility disorder. Uncommon: Blurred vision, mydriasis, intraocular pressure increased, eye pain, halo vision, conjunctival hyperemia, corneal oedema, glaucoma, anaphylactic reaction, hypersensitivity, angioedema of tongue, lips & face, palpitations, supraventricular tachycardia, bronchospasm, paradoxical bronchospasm, laryngospasm, pharyngeal oedema, dry throat, diarrhea, constipation, vomiting, stomatitis, rash, pruritus and urinary retention. Rare: Accommodation disorder, atrial fibrillation, heart rate increased and urticaria.

Known drug interactions: Administration of ipratropium bromide with beta-adrenergics and xanthine preparations may intensify the bronchodilator effect. Co-Administration of ipratropium bromide with other anticholinergic drugs should be avoided, as this may lead to an increase in anticholinergic adverse effects.

Frequently bought together

Bundle total

Rs. 3,445Rs. 3,740

Related concerns

Related reading

Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.